Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function

John H. Lemmer, William Stanford, Sharon L. Bonney, Eva V. Chomka, Robert B. Karp, Glenn W. Laub, John A. Rumberger, Hartzell V Schaff

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Two hundred sixteen patients undergoing coronary artery bypass graft procedures were randomized to receive either high-dose aprotinin or placebo. Clinically important postoperative renal insufficiency was infrequent, with a single patient (0.9%) from each group requiring dialysis. Although increases in the serum creatinine level occurred postoperatively in more patients who received aprotinin (20/108) than in those given placebo (13/108), the difference between the two group was not statistically significant (p = 0.186), and the increases were generally small and transient. Likewise, there was no difference between the groups in terms of the incidence of abnormal serum electrolyte levels, blood era nitrogen levels, or urinalysis findings, or in the frequency of abnormal creatinine clearance rates. Under the conditions described, aprotinin use does not appear to be associated with a significant risk of serious renal toxicity.

Original languageEnglish (US)
Pages (from-to)132-136
Number of pages5
JournalThe Annals of Thoracic Surgery
Volume59
Issue number1
DOIs
StatePublished - 1995

Fingerprint

Aprotinin
Coronary Artery Bypass
Kidney
Creatinine
Placebos
Urinalysis
Serum
Electrolytes
Renal Insufficiency
Dialysis
Nitrogen
Transplants
Incidence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Aprotinin for coronary artery bypass grafting : Effect on postoperative renal function. / Lemmer, John H.; Stanford, William; Bonney, Sharon L.; Chomka, Eva V.; Karp, Robert B.; Laub, Glenn W.; Rumberger, John A.; Schaff, Hartzell V.

In: The Annals of Thoracic Surgery, Vol. 59, No. 1, 1995, p. 132-136.

Research output: Contribution to journalArticle

Lemmer, JH, Stanford, W, Bonney, SL, Chomka, EV, Karp, RB, Laub, GW, Rumberger, JA & Schaff, HV 1995, 'Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function', The Annals of Thoracic Surgery, vol. 59, no. 1, pp. 132-136. https://doi.org/10.1016/0003-4975(94)00813-M
Lemmer, John H. ; Stanford, William ; Bonney, Sharon L. ; Chomka, Eva V. ; Karp, Robert B. ; Laub, Glenn W. ; Rumberger, John A. ; Schaff, Hartzell V. / Aprotinin for coronary artery bypass grafting : Effect on postoperative renal function. In: The Annals of Thoracic Surgery. 1995 ; Vol. 59, No. 1. pp. 132-136.
@article{f96a6329769b40d5bdaa99c06a7e3964,
title = "Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function",
abstract = "Two hundred sixteen patients undergoing coronary artery bypass graft procedures were randomized to receive either high-dose aprotinin or placebo. Clinically important postoperative renal insufficiency was infrequent, with a single patient (0.9{\%}) from each group requiring dialysis. Although increases in the serum creatinine level occurred postoperatively in more patients who received aprotinin (20/108) than in those given placebo (13/108), the difference between the two group was not statistically significant (p = 0.186), and the increases were generally small and transient. Likewise, there was no difference between the groups in terms of the incidence of abnormal serum electrolyte levels, blood era nitrogen levels, or urinalysis findings, or in the frequency of abnormal creatinine clearance rates. Under the conditions described, aprotinin use does not appear to be associated with a significant risk of serious renal toxicity.",
author = "Lemmer, {John H.} and William Stanford and Bonney, {Sharon L.} and Chomka, {Eva V.} and Karp, {Robert B.} and Laub, {Glenn W.} and Rumberger, {John A.} and Schaff, {Hartzell V}",
year = "1995",
doi = "10.1016/0003-4975(94)00813-M",
language = "English (US)",
volume = "59",
pages = "132--136",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Aprotinin for coronary artery bypass grafting

T2 - Effect on postoperative renal function

AU - Lemmer, John H.

AU - Stanford, William

AU - Bonney, Sharon L.

AU - Chomka, Eva V.

AU - Karp, Robert B.

AU - Laub, Glenn W.

AU - Rumberger, John A.

AU - Schaff, Hartzell V

PY - 1995

Y1 - 1995

N2 - Two hundred sixteen patients undergoing coronary artery bypass graft procedures were randomized to receive either high-dose aprotinin or placebo. Clinically important postoperative renal insufficiency was infrequent, with a single patient (0.9%) from each group requiring dialysis. Although increases in the serum creatinine level occurred postoperatively in more patients who received aprotinin (20/108) than in those given placebo (13/108), the difference between the two group was not statistically significant (p = 0.186), and the increases were generally small and transient. Likewise, there was no difference between the groups in terms of the incidence of abnormal serum electrolyte levels, blood era nitrogen levels, or urinalysis findings, or in the frequency of abnormal creatinine clearance rates. Under the conditions described, aprotinin use does not appear to be associated with a significant risk of serious renal toxicity.

AB - Two hundred sixteen patients undergoing coronary artery bypass graft procedures were randomized to receive either high-dose aprotinin or placebo. Clinically important postoperative renal insufficiency was infrequent, with a single patient (0.9%) from each group requiring dialysis. Although increases in the serum creatinine level occurred postoperatively in more patients who received aprotinin (20/108) than in those given placebo (13/108), the difference between the two group was not statistically significant (p = 0.186), and the increases were generally small and transient. Likewise, there was no difference between the groups in terms of the incidence of abnormal serum electrolyte levels, blood era nitrogen levels, or urinalysis findings, or in the frequency of abnormal creatinine clearance rates. Under the conditions described, aprotinin use does not appear to be associated with a significant risk of serious renal toxicity.

UR - http://www.scopus.com/inward/record.url?scp=0028891130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028891130&partnerID=8YFLogxK

U2 - 10.1016/0003-4975(94)00813-M

DO - 10.1016/0003-4975(94)00813-M

M3 - Article

C2 - 7529484

AN - SCOPUS:0028891130

VL - 59

SP - 132

EP - 136

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 1

ER -